BIOMAT Database Logo BIOMAT Database Logo

Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. 1998

J E Fenyk-Melody, and A E Garrison, and S R Brunnert, and J R Weidner, and F Shen, and B A Shelton, and J S Mudgett
Merck Research Laboratories, Rahway, NJ 07065, USA.

Nitric oxide is believed to be a prominent mediator of inflammation based in part on the correlative expression of the inducible nitric oxide synthase (iNOS) gene in various pathologies. The resulting high output of the highly reactive molecule nitric oxide is then believed to play an important role in the evolving inflammatory response. Studies have shown that iNOS and nitric oxide are present in the tissues of patients with multiple sclerosis (MS). In rodent models of MS, experimental autoimmune encephalomyelitis (EAE), it has been shown that nonspecific NOS inhibitors partially ameliorate the disease. To determine the importance of iNOS in this model of MS, we induced EAE in mice containing a disrupted iNOS (NOS2) gene. Surprisingly, by day 24, the NOS2 knockout mice had a greater incidence of EAE than wild-type control mice (75 vs 12%), and had a higher average severity score (2.42 vs 0.44). These differences appear to result largely from the failure of the disease to remit in NOS2 KO mice. Wild-type mice have a profound ability to reverse EAE (82%) compared with the knockout mice (19%). This result implies that iNOS may in some instances play a protective role in autoimmune-mediated tissue destruction.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D004681 Encephalomyelitis, Autoimmune, Experimental An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5) Autoimmune Encephalomyelitis, Experimental,Encephalomyelitis, Allergic,Encephalomyelitis, Experimental Autoimmune,Allergic Encephalomyelitis,Allergic Encephalomyelitis, Experimental,Autoimmune Experimental Encephalomyelitis,Experimental Allergic Encephalomyelitis,Experimental Autoimmune Encephalomyelitis,Encephalomyelitis, Autoimmune Experimental,Encephalomyelitis, Experimental Allergic,Experimental Allergic Encephalomyelitides,Experimental Encephalomyelitis, Autoimmune
D005260 Female Females
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D052247 Nitric Oxide Synthase Type II A CALCIUM-independent subtype of nitric oxide synthase that may play a role in immune function. It is an inducible enzyme whose expression is transcriptionally regulated by a variety of CYTOKINES. INOS Enzyme,Inducible NOS Protein,Inducible Nitric Oxide Synthase,NOS-II,Nitric Oxide Synthase II,Nitric Oxide Synthase, Type II,NOS II
D018345 Mice, Knockout Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes. Knockout Mice,Mice, Knock-out,Mouse, Knockout,Knock-out Mice,Knockout Mouse,Mice, Knock out
D019001 Nitric Oxide Synthase An NADPH-dependent enzyme that catalyzes the conversion of L-ARGININE and OXYGEN to produce CITRULLINE and NITRIC OXIDE. NO Synthase,Nitric-Oxide Synthase,Nitric-Oxide Synthetase,Nitric Oxide Synthetase,Oxide Synthase, Nitric,Synthase, Nitric Oxide

Related Publications

J E Fenyk-Melody, and A E Garrison, and S R Brunnert, and J R Weidner, and F Shen, and B A Shelton, and J S Mudgett
Mice lacking myeloperoxidase are more susceptible to experimental autoimmune encephalomyelitis.
January 2001, Journal of neuroimmunology,
J E Fenyk-Melody, and A E Garrison, and S R Brunnert, and J R Weidner, and F Shen, and B A Shelton, and J S Mudgett
Cardiac hypertrophy is exacerbated in aged mice lacking the osteoprotegerin gene.
May 2016, Cardiovascular research,
J E Fenyk-Melody, and A E Garrison, and S R Brunnert, and J R Weidner, and F Shen, and B A Shelton, and J S Mudgett
Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis.
February 1999, Journal of neurovirology,
J E Fenyk-Melody, and A E Garrison, and S R Brunnert, and J R Weidner, and F Shen, and B A Shelton, and J S Mudgett
Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh/W-sh mice.
April 2011, Laboratory investigation; a journal of technical methods and pathology,
J E Fenyk-Melody, and A E Garrison, and S R Brunnert, and J R Weidner, and F Shen, and B A Shelton, and J S Mudgett
Experimental Autoimmune Encephalomyelitis in Mice.
January 2016, Methods in molecular biology (Clifton, N.J.),
J E Fenyk-Melody, and A E Garrison, and S R Brunnert, and J R Weidner, and F Shen, and B A Shelton, and J S Mudgett
NOS2 regulates cytokine production and VLA-4 expression in experimental autoimmune encephalomyelitis.
April 2006, Journal of neuroimmunology,
J E Fenyk-Melody, and A E Garrison, and S R Brunnert, and J R Weidner, and F Shen, and B A Shelton, and J S Mudgett
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.
October 2000, The Journal of experimental medicine,
J E Fenyk-Melody, and A E Garrison, and S R Brunnert, and J R Weidner, and F Shen, and B A Shelton, and J S Mudgett
ICOS deficiency results in exacerbated IL-17 mediated experimental autoimmune encephalomyelitis.
July 2009, Journal of clinical immunology,
J E Fenyk-Melody, and A E Garrison, and S R Brunnert, and J R Weidner, and F Shen, and B A Shelton, and J S Mudgett
Gene therapy in experimental autoimmune encephalomyelitis.
September 2000, Journal of clinical immunology,
J E Fenyk-Melody, and A E Garrison, and S R Brunnert, and J R Weidner, and F Shen, and B A Shelton, and J S Mudgett
Mice lacking alpha beta + T cells are resistant to the induction of experimental autoimmune encephalomyelitis.
November 1996, Journal of neuroimmunology,
Copied contents to your clipboard!